| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |